Number of items: 6.
2022
Alpizar-Sosa, E. A. et al.
(2022)
Amphotericin B resistance in Leishmania mexicana: Alterations to sterol metabolism and oxidative stress response.
PLoS Neglected Tropical Diseases, 16(9),
e0010779.
(doi: 10.1371/journal.pntd.0010779)
(PMID:36170238)
(PMCID:PMC9581426)
2021
Steketee, P. C. et al.
(2021)
Divergent metabolism between Trypanosoma congolense and Trypanosoma brucei results in differential sensitivity to metabolic inhibition.
PLoS Pathogens, 17(7),
e1009734.
(doi: 10.1371/journal.ppat.1009734)
(PMID:34310651)
(PMCID:PMC8384185)
Mina, J. G.M. et al.
(2021)
Antileishmanial chemotherapy through clemastine fumarate mediated inhibition of the Leishmania inositol phosphorylceramide synthase.
ACS Infectious Diseases, 7(1),
pp. 47-63.
(doi: 10.1021/acsinfecdis.0c00546)
(PMID:33291887)
(PMCID:PMC7802075)
2020
Cockram, Peter E., Dickie, Emily A., Barrett, Michael P.
ORCID: https://orcid.org/0000-0001-9447-3519 and Smith, Terry K.
(2020)
Halogenated tryptophan derivatives disrupt essential transamination mechanisms in bloodstream form Trypanosoma brucei.
PLoS Neglected Tropical Diseases, 14(12),
e0008928.
(doi: 10.1371/journal.pntd.0008928)
(PMID:33275612)
(PMCID:PMC7744056)
Dickie, Emily A., Giordani, Federica
ORCID: https://orcid.org/0000-0001-9964-281X, Gould, Matthew K., Maeser, Pascal, Burri, Christian, Mottram, Jeremy C.
ORCID: https://orcid.org/0000-0001-5574-3766, Rao, Srinivasa P.S. and Barrett, Michael P.
ORCID: https://orcid.org/0000-0001-9447-3519
(2020)
New drugs for human African trypanosomiasis:a twenty first century success story.
Tropical Medicine and Infectious Disease, 5(1),
29.
(doi: 10.3390/tropicalmed5010029)
(PMID:32092897)
(PMCID:PMC7157223)
2019
Dickie, Emily A., Young, Simon A. and Smith, Terry K.
(2019)
Substrate specificity of the neutral sphingomyelinase from Trypanosoma brucei.
Parasitology, 146(5),
pp. 604-616.
(doi: 10.1017/S0031182018001853)
(PMID:30392480)
This list was generated on Sun Jun 15 16:01:11 2025 BST.